Skip to content

Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women

Establishing the Diagnosis Standard and Analysis the Risk Factors of Premature Ovarian Insufficiency in Chinese Women: Multi-center, Prospective,Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03518918
Enrollment
50000
Registered
2018-05-08
Start date
2016-09-01
Completion date
2021-12-01
Last updated
2018-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Ovarian Insufficiency

Keywords

Premature ovarian insufficiency, Diagnosis standard, Risk factors

Brief summary

The study aims to establishing the diagnosis standard of POI and analyzing the risk factors in Chinese women.

Detailed description

Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. The POI guideline development group of ESHRE recommends the following diagnostic criteria: oligo/amenorrhea for at least 4 months and an elevated follicle stimulating hormone (FSH) level \>25 mIU/mL on two occasion \>4 weeks apart. But there still no diagnosis standard of POI in Chinese.The study aims to establishing the diagnosis standard of POI and analyzing the risk factors in Chinese women.

Interventions

None listed

Sponsors

Queen Mary Hospital, Hong Kong
CollaboratorOTHER
Southern Medical University, China
CollaboratorOTHER
The Third Affiliated Hospital of Southern Medical University
CollaboratorOTHER_GOV
Shenzhen Hospital of Southern Medical University
CollaboratorOTHER
Shen-Zhen City Maternity and Child Healthcare Hospital
CollaboratorOTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
12 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Infertility * The length of menstrual cycle longer than 35 days or shorter than/amenorrhea * Serum FSH levels ≥10mIU/ml/ serum AMH levels ≤1.0pg/ml/ AFC ≤7, on at least two occasion \>4 weeks apart

Exclusion criteria

* Polycystic Ovarian Syndrome * other causes of amenorrhea

Design outcomes

Primary

MeasureTime frameDescription
Change of serum FSH levelsthrough study completion, an average of 3 months, assessed up to 48 monthsthe serum FSH levels between day 2 to day 5 of menstrual cycle from date of recruit until the date of study completion or date of twice FSH level \>25mIU/mL, whichever came first.
Menstruation situationthrough study completion, an average of 3 months, assessed up to 48 monthsthe length of the menstrual cycle from date of recruit until the date of study completion or date of twice FSH level \>25mIU/mL, whichever came first.

Secondary

MeasureTime frameDescription
Change of Antral follicle countthrough study completion, an average of 3 months, assessed up to 48 monthsthe Antral follicle count between day 2 to day 5 of menstrual cycle from date of recruit until the date of study completion or date of twice FSH level \>25mIU/mL, whichever came first.
Change of anti-mullerian hormone levelsthrough study completion, an average of 3 months, assessed up to 48 monthsthe anti-mullerian hormone between day 2 to day 5 of menstrual cycle from date of recruit until the date of study completion or date of twice FSH level \>25mIU/mL, whichever came first.

Countries

China

Contacts

Primary ContactShi-ling Chen, M.D, Ph.D
chensl_92@163.com+86-020-62787604

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026